Statistical Consulting

Experts in statistical consulting deliver strategic insight, advanced methods, and tech-enabled support for confident decision-making for clinical development.

At MMS, our Clinical Statistical Consulting Services are designed to go beyond analysis. We bring partnership, foresight, and innovation to every stage of your clinical development journey. Our consultants provide the clarity, technical expertise, and technology-enabled solutions needed to make confident, data-driven decisions that move your program forward.

Flexible, Integrated Project Support

Our statistical consulting experts are more than technical leads, they are embedded partners. MMS collaborate closely with sponsors, adapting to your unique needs, timelines, and teams. With deep industry knowledge and end-to-end development experience, our statisticians bring flexibility, responsiveness, and strategic foresight to every engagement.

How MMS Delivers Value:

  • Trusted partnership from experienced statisticians
  • Seamless integration with cross-functional teams including programming, data management, data science, medical writing, and clinical operations.
  • Clear, contextualized communication of statistical rationale
  • Flexible support across the development lifecycle

Study Design Support and Evaluation

We deliver evidence-based, pragmatic guidance to help sponsors evaluate risk, explore options, and make the right choices early. Our team of MMS experts applies a variety of simulation tools and statistical techniques to assess your study design, development plan, and strategic opportunities allowing your clinical development teams to maximize probability of success and adjust when needed.

MMS Supports Clinical Teams With:

  • Study design and development plan evaluation
  • Estimand strategies and protocol input
  • Use of our technology enabled solutions KerusCloud® to model outcomes and optimize trial design
  • Critical review and amendment of existing designs

Custom Strategies for your Development Pipeline

Our statisticians are equipped to implement complex and novel methodologies tailored to the needs of your asset. Whether using Bayesian frameworks, designing synthetic control arms, or advising on estimands selection, we ensure the right technical solution is applied with clarity and rigor.

Tailored MMS Solutions Include:

  • Complex analysis using Bayesian and other advanced methods
  • Application of appropriate estimands strategies
  • Implementation of external or synthetic control arms
  • Quantitative support for investment decisions

Regulatory Engagement

MMS statisticians act as authoritative voices and trusted advocates for your program. From regulatory meetings to vendor oversight and independent statistical roles, we ensure that your statistical interests are clearly represented, protected, and aligned with your development goals.

How MMS Can Support:

  • Regulatory submission and meeting preparation
  • Oversight of external data or statistical vendors
  • Independent statistician roles for monitoring committees
  • High-quality deliverables aligned with regulatory expectations

Suggested For You

perspectives

February 10th, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

perspectives

February 3rd, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

ebook

January 27th, 2026

A Practical Guide to Expedited Regulatory Pathways

perspectives

January 27th, 2026

What Regulators Want to See in Surrogate Endpoints Today 

perspectives

January 20th, 2026

Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration 

perspectives

January 13th, 2026

Making Clinical Trial Technology Work in Practice

fact sheet

December 17th, 2025

Advance Psychedelic Drug Development With Proven Regulatory and Data Expertise

fact sheet

December 17th, 2025

Agile Medical Writing Staff Augmentation When You Need Expertise Not Headcount

fact sheet

December 17th, 2025

Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials

whitepaper

December 17th, 2025

Estimands: Opportunity or Risk for Drug Developers?